Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum

BACKGROUND: The N-MOmentum trial investigated safety and efficacy of inebilizumab in participants with neuromyelitis optica spectrum disorder (NMOSD). OBJECTIVE: Evaluate the attack identification process and adjudication committee (AC) performance in N-MOmentum. METHODS: Adults (n = 230) with NMOSD...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinshenker, Brian G, Wingerchuk, Dean M, Green, Ari J, Bennett, Jeffrey L, Kim, Ho Jin, Pittock, Sean J, Fujihara, Kazuo, Paul, Friedemann, Cutter, Gary, Marignier, Romain, Aktas, Orhan, Hartung, Hans-Peter, She, Dewei, Smith, Michael, Rees, William, Patterson, Kristina, Cimbora, Daniel, Katz, Eliezer, Cree, Bruce AC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338695/
https://www.ncbi.nlm.nih.gov/pubmed/37282545
http://dx.doi.org/10.1177/13524585231172145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338695/
https://www.ncbi.nlm.nih.gov/pubmed/37282545
http://dx.doi.org/10.1177/13524585231172145

Ejemplares similares